Literature DB >> 22766375

Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents.

Ajay Kumar1, Kamla Pathak, Vikas Bali.   

Abstract

The skin acts as a barrier and prevents transcutaneous delivery of therapeutic agents. Transferosomes are novel vesicular systems that are several times more elastic than other vesicular systems. These are composed of phospholipids, edge activator and ethanol and are applied in a non-occlusive manner. Owing to their ultradeformability, they have the potential to deliver therapeutic agents across the intact skin in a non-invasive and non-allergenic manner. The present review attempts to provide an in-depth account of ultra-adaptable nanovesicular systems. The current investigation, besides compiling existing knowledge in a systematic manner, also includes information like regulatory aspects of excipients used in preparation, summary of clinical investigations performed, marketed preparations available, research reports and patent reports related to transfersomes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766375     DOI: 10.1016/j.drudis.2012.06.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

Review 1.  Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease.

Authors:  Paul Lawrence; Joseph Ceccoli
Journal:  BioDrugs       Date:  2017-10       Impact factor: 5.807

2.  Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization.

Authors:  Rui Su; Wufa Fan; Qin Yu; Xiaochun Dong; Jianping Qi; Quangang Zhu; Weili Zhao; Wei Wu; Zhongjian Chen; Ye Li; Yi Lu
Journal:  Oncotarget       Date:  2017-06-13

3.  Mechanisms of deformable nanovesicles based on insulin-phospholipid complex for enhancing buccal delivery of insulin.

Authors:  You Xu; Xing Zhang; Yun Zhang; Jun Ye; Hong-Liang Wang; Xuejun Xia; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2018-11-09

4.  Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation.

Authors:  Rofida Albash; Aly A Abdelbary; Hanan Refai; Mohamed A El-Nabarawi
Journal:  Int J Nanomedicine       Date:  2019-03-15

Review 5.  Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.

Authors:  Abdul Ahad; Mohammad Raish; Yousef A Bin Jardan; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

Review 6.  Vesicular systems for dermal and transdermal drug delivery.

Authors:  Claire Richard; Stéphanie Cassel; Muriel Blanzat
Journal:  RSC Adv       Date:  2020-12-23       Impact factor: 3.361

Review 7.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03

Review 8.  Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations.

Authors:  Eder Lilia Romero; Maria Jose Morilla
Journal:  Int J Nanomedicine       Date:  2013-08-20

9.  Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.

Authors:  Abdurrahman M Fahmy; Doaa Ahmed El-Setouhy; Ahmed B Ibrahim; Basant A Habib; Saadia A Tayel; Noha A Bayoumi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  Enhancement strategies for transdermal drug delivery systems: current trends and applications.

Authors:  Delly Ramadon; Maeliosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-01-20       Impact factor: 4.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.